ICH Q2(R2)，Q14ガイドラインの作成状況と論点解説─(2)

DOI
  • 檜山 行雄
    ICH Q2(R2)Q14専門家会議ラポーター 国立医薬品食品衛生研究所薬品部客員研究員

書誌事項

タイトル別名
  • Drafting Process and key Points of ICH Q2(R2) and Q14 Guideline (2)

この論文をさがす

説明

<p>This article describes the drafting process and key points of ICH Q2(R2)(Analytical Validation) and ICH Q14(Analytical Development). The harmonization effort started in 2018 and the two documents are being drafted by one Expert Working Group. The drafts for public consultation will be published in early 2022. The revised Q2 will include spectroscopic procedures, procedures used for biologics, multivariate analysis based procedures, etc. The new Q14 will cover Enhanced (Quality by Design) development approach. Q14 emphasizes that the enhanced knowledge supports robust analytical procedures and their effective lifecycle management.</p>

収録刊行物

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ